Details of the Drug

General Information of Drug (ID: DM103O8)

Drug Name
Ligelizumab
Synonyms QGE031
Indication
Disease Entry ICD 11 Status REF
Chronic idiopathic urticaria EB00.1 Phase 3 [1]
Drug Type
Antibody
Cross-matching ID
DrugBank ID
DB11856
TTD ID
DS4U1W

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Immunoglobulin E (IgE) TTYJQTF NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04210843) Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Novartis.